IL-4, IL-10 and IFN-γ have distinct, but interacting, effects on differentiation-induced changes in TNF-α and TNF receptor release by cultured human monocytes

Cytokine

Volumn 8, Issue 1, 1996, Pages 49-57

  Joyce, David A ^b   Steer, James H ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b NONE

Author keywords

IL 10; IL 4; Monocytes; TNF receptor; TNF

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKOCYTE CULTURE; MONOCYTE; PRIORITY JOURNAL;

EID: 0029944865     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0007     Document Type: Article

References (57)

1. Imamura K, Spriggs D, Kufe D (1987) Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand. J Immunol 139:2989-2992.
2. Nophar Y, Kemper O, Brakebusch C, Engelmann H, Zwang R, Aderka D, Holtmann H, Wallach D (1990) Soluble forms of tumor necrosis receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J 9:3269-3278.
3. Kohno T, Brewer MT, Baker SL, Schwartz PE, King MW, Hale KK, Squires CH, Thompson RC, Vannice JL. (1990) A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA 87:8331-8335.
4. Olsson I, Lantz M, Nilsson E, Peetre C, Thysell H, Grubb A, Adolf G (1989) Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol 42:270-275.
5. Seckinger P, Isaaz S, Dayer JM (1989) Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor. J Biol Chem 264:11966-11973.
6. Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D (1989) A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 264:11974-11980.
7. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, Madani H, Widmer MB (1994) Soluble Tumor Necrosis Factor (TNF) Receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151:1548-1561.
8. Lantz M, Gullberg U, Nilsson E, Olsson I (1990) Characterization in vitro of a human tumor necrosis factor-binding protein: a soluble form of a tumor necrosis factor receptor. J Clin Invest 86:1396-1402.
9. Peppel K, Crawford D, Beutler B (1991) A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J Exp Med 174:1483-1489.
10. Loetscher H, Gentz R, Zulauf M, Lustig A, Tabuchi H, Schlaeger EJ, Brockhaus M, Gallati H, Manneberg M, Lesslauer W (1991) Recombinant 55-kDa tumor necrosis factor (TNF) receptor: Stoichiometry of binding to TNF-α and TNF-β and inhibition of TNF activity. J Biol Chem 266:18324-18329.
11. Bemelmans MHA, Gouma DJ, Buurman WA (1993) Influence of nephrectomy on tumor necrosis factor clearance in a murine model. J Immunol 150:2007-2017.
12. Cope AP, Aderka D, Doherty M, Engelmann H, Gibbons D, Jones AC, Brennan FM, Maini RN, Wallach D, Feldmann M (1992) Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 35:1160-1169.
13. Aderka D, Engelmann H, Hornik V, Skornick Y, Levo Y, Wallach D, Kushtai G (1991) Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res 51:1-6.
14. Liabakk N, Sundan A, Waage A, Brockhaus M, Loetcher H, Lesslauer W,Espevik T (1991) Development of immunoassays for the detection of soluble tumor necrosis factor receptors. J Immunol Meth 141:237-243.
15. Chikanza IC, Rouxlombard P, Dayer JM, Panayi GS (1993) Tumour necrosis factor soluble receptors behave as acute phase reactants following surgery in patients with rheumatoid arthritis, chronic osteomyelitis and osteoarthritis. Clin Exp Immunol 92:19-22.
16. Joyce DA, Gibbons DP, Green P, Steer JH, Feldmann M, Brennan FM (1994) Two inhibitors of pro-inflammatory cytokine release, IL-10 and IL-4, have contrasting effects on the release of soluble p75 TNF receptor by cultured human monocytes. Eur J Immunol 24:2699-2705.
17. Lantz M, Malik S, Slevin M, Olsson I (1990) Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine 2:402-406.
18. Fiers W (1991) Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. [Review]. FEBS Lett 285:199-212.
19. Leeuwenberg JFM, Jeunhomme TMAA, Buurman WA (1994) Slow release of soluble TNF receptors by monocytes in vitro. J Immunol 152:4036-4043.
20. Leeuwenberg JF, Dentener MA, Buurman WA (1994) Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD 14, LPS binding protein, and bactericidal permeability-increasing protein. J Immunol 152:5070-5076.
21. Janson RW, Hance KR, Arend WP (1991) Production of IL-1 receptor antagonist by human in vitro-derived macrophages: Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor. J Immunol 147:4218-4223.
22. Deleuran BW, Chu C, Field M, Brennan FM, Mitchell T, Feldmann M, Maini RN (1992) Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis: Implications for local actions of tumor necrosis factor alpha. Arthritis Rheum 35:1170-1178.
23. Collart MA, Belin D, Vassalli J, de Kossodo S, Vassalli P (1986) γ-interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1 and urokinase genes, which are controlled by short-lived repressers. J Exp Med 164:2113-2118.
24. Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA (1992) Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. J Immunol 149:1666-1670.
25. Bemelmans MH, Gouma DJ, Buurman WA (1993) LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-γ. J Immunol 151:5554-5562.
26. Scheurich P, Kobrich G, Pfizenmaier K (1989) Antagonistic control of tumor necrosis factor receptors by protein kinases A and C: Enhancement of TNF receptor synthesis by protein kinase A and transmodulation of receptors by protein kinase C. J Exp Med 170:947-958.
27. Drapier J, Weitzerbin J (1991) INF-γ reduces specific binding of tumor necrosis factor on murine macrophages. J Immunol 146:1198-1203.
28. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220.
29. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 179:1109-1118.
30. Takashima T, Ohnishi K, Tsuyuguchi I, Kishimoto S (1993) Differential regulation of formation of multinucleated giant cells from concanavalin-A-stimulated human blood monocytes by IFN-γ and IL-4. J Immunol 150:3002-3010.
31. te Velde A A, Klomp JPG, Yard BA, de Vries JE, Figdor CG (1988) Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. J Immunol 140:1548-1554.
32. Mangan DF, Welch GR, Wahl SM (1991) Lipopolysaccharide, tumor necrosis factor-a, and IL-1β prevent programmed cell death (apoptosis) in human peripheral blood-monocytes. J Immunol 146:1541-1546.
33. Katsikis P, Chu C, Brennan FM, Maini RN, Feldmann M (1994) Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 179:1517-1527.
34. Navikas V, Link J, Palasik W, Söderström M, Fredrikson S, Olsson T, Link H (1995) Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis. Scand J Immunol 41:171-178.
35. Landmann R, Ludwig C, Obrist R, Obrecht JP (1991) Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages. J Cell Biochem 47:317-329.
36. 2. Proc Natl Acad Sci USA 86:3803-3807.
37. Han J, Thompson P, Beutler B (1990) Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 172:391-394.
38. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G (1993) Thalidomide exerts its inhibitory action on tumor necrosis factor aby enhancing mRNA degradation. J Exp Med 177:1675-1680.
39. Joyce DA, Steer JH, Beilharz M, Stranger R (1995) A system for assessment of monokine gene expression using human whole blood. Genetic Analysis: Biomolecular Engineering 12:39-43.
40. Wang P, Wu P, Siegel MI, Egan RW, Billah MM (1994) IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 153:811-817.
41. Tannenbaum CS, Major JA, Hamilton TA (1993) IFN-γand lipopolsaccharide differentially modulate expression of tumor necrosis factor receptor mRNA in murine peritoneal macrophages. J Immunol 151:6833-6839.
42. Ruggiero V, Tavernier J, Fiers W, Baglioni C (1986) Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma. J Immunol 136:2445-2450.
43. Tsujimoto M, Feinman R, Vilcek J (1986) Differential effects of type I IFN and IFN-γ on the binding of tumor necrosis factor to receptors in two human cell lines. J Immunol 137:2272-2276.
44. Howard M, Muchamuel T, Andrade S, Menon S (1993) Interleukin-10 protects mice from lethal endotoxemia. J Exp Med 177:1205-1208.
45. de Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, de Vries JE (1992) Interleukin-10. [Review]. Curr Opin Immunol 4:314-320.
46. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915-924.
47. Bogdan C, Paik J, Vodovotz Y, Nathan C (1992) Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem 267:23301-23308.
48. Wanidworanun C, Strober W (1993) Predominant role of tumor necrosis factor-a in human monocyte IL-10 synthesis. J Immunol 151:6853-6861.
49. Chomarat P, Rissoan MC, Banchereau J, Miossec P (1993) Interferon gamma inhibits interleukin 10 production by monocytes. J Exp Med 177:523-527.
50. Cope AP, Gibbons DL, Aderka D, Foxwell BM, Wallach D, Maini RN, Feldmann M, Brennan FM (1993) Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cells. Cytokine 5:205-212.
51. Krakauer T, Oppenheim JJ (1993) IL-1 and tumor necrosis factor-α each upregulate both the expression of IFN-γ receptors and enhance IFN-γ-induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1). J Immunol 150:1205-1211.
52. Winzen R, Wallach D, Kemper O, Resch K, Holtmann H (1993) Selective upregulation of the 75-kDa tumor necrosis factor (TNF) receptor and Its messenger RNA by TNF and IL-1. J Immunol 150:4346-4353.
53. Kalthoff H, Roeder C, Brockhaus M, Thiele HG, Schmiegel W. (1993) Tumor necrosis factor (TNF) up-regulates the expression of p75 but not p55 TNF receptors, and both receptors mediate, independently of each other, up-regulation of transforming growth factor-alpha and epidermal growth factor receptor messenger RNA. J Biol Chem 268:2762-2766.
54. Higuchi M, Aggarwal BB (1994) TNF induces internalization of the p60 and shedding of the p80 receptor. J Immunol 152:3550-3558.
55. Labarca C, Paigen K (1980) A simple, rapid and sensitive DNA assay procedure. Anal Biochem 102:344-352.
56. - T cells that express the αβ T-cell receptor and respond to interleukins 2, 3, and 4. Proc Natl Acad Sci USA 86:8502-8506.
57. Kelly RB, Cozzarelli NR, Deutscher MP, Lehman JR, Kornberg A (1970) Enzymatic synthesis of deoxyribonucleic acid. XXXII. Replication of duplex deoxyribonucleic acid by polymerase at a single strand break. J Biol Chem 245:39-45.